SNDX — SYNDAX PHARMACEUTICALS INC

Ownership history in Scientech Research LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Scientech Research LLC reported a position in SYNDAX PHARMACEUTICALS INC (SNDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.3% (2024 Q1)
Avg. % of fund
0.23%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 30,875 +7,355 +31.3% 0.17% $475K $15.39
2024 Q1 INITIATED 23,520 — — 0.30% $560K —
% of Fund (quarterly)    SNDX price (monthly, adj. close)

Other funds also holding SNDX

As of 2025 Q4 — sorted by position size

Elmind Capital, LP 11.5% Kynam Capital Management, LP 3Y 10.81% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 5.87% Aisling Capital Management LP 3Y 7Y 5.78% STEMPOINT CAPITAL LP 4.83% Catalio Capital Management, LP 4.44% Knott David M Jr 3Y 4.04% Lion Point Capital, LP 3Y 7Y 3.91% Eversept Partners, LP 3Y 7Y 3.51% MPM BioImpact LLC 3Y 3.22%
← Back to Scientech Research LLC Holdings